A phase 1 multi-center, dose escalation and pharmacokinetic study of L-NDDP (Aroplatin) in patients with advanced solid malignancies or B-cell lymphoma
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2016
At a glance
- Drugs L NDDP (Primary)
- Indications B cell lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Agenus
- 24 Oct 2008 Status changed from recruiting to completed, based on information from ClinicalTrials.gov.
- 27 Jul 2006 Status change
- 30 Mar 2006 New trial record.